LLY and BIIB Related Headlines
Go Back- Midday movers: Costco, Marvell fall; Gap, DocuSign rise
- FDA to delay decision on Eli Lilly Alzheimer's drug for second time
- Biogen (BIIB) gain as Eli Lilly's AD drug delayed by FDA
- 6 healthcare stocks Argus considers 'gems'
- Argus sees 'some possible gems right now in the Healthcare sector'
- Biogen price target raised at BofA following results from Lilly in early Alzheimer's disease
- Biogen (BIIB): Lilly's competitive AD drug news a positive, not negative - Baird
- Biogen (BIIB) Falls 5% Following Results From Lilly (LLY) in Early Alzheimer's Disease
